Psychiatric disorders Archives

Podcast 15 Aug 2025

Are next-generation psychedelics the way forward for addressing treatment resistant depression?

This week’s guest is Cosmo Feilding of Beckley PsyTech, a UK biotech working with next generation psychedelics that could redefine depression treatment.

August 15, 2025

Best in Biotech 12 Aug 2025

Six psychedelic drug companies aiming to revolutionize mental health treatment

Discover six of the top psychedelic companies developing novel drugs to expand the treatment scope for mental health indications.

August 12, 2025 - 3 minutesmins - By Willow Shah-Neville

In Depth 27 Jun 2025

Psychedelics sans side effects: neuroplastogens gain ground

The past year has seen several developments in the neuroplastogens field, including Elkedonia’s seed funding to address neuropsychiatric disorders.

June 27, 2025 - 8 minutesmins - By Roohi Mariam Peter

News and Trends 21 Mar 2025

Depression drug trials are failing—and placebos are to blame

In this article, we examine recent clinical trial failures and discuss potential pathways forward for antidepressant drug research.

March 21, 2025 - 9 minutesmins - By Roohi Mariam Peter

In Depth 12 Sep 2024

New treatments being developed for schizophrenia

Explore the latest strides in schizophrenia treatment development as 2024 heralds a pivotal year, with promising collaborations and trials.

September 12, 2024

Psychedelic therapy market: FDA rejects Lykos' MDMA treatment

News and Trends 6 Sep 2024

Psychedelic therapies under scrutiny: What’s next after Lykos’ MDMA rejection?

Delve into the psychedelic-assisted therapy market and investors’ sentiment after the FDA’s decision about Lykos’ therapy.

September 6, 2024 - 8 minutesmins - By Jules Adam

Best in Biotech 25 Jan 2024

Eight mental health biotech companies trying to make a difference to people’s lives

Take a closer look at eight mental health companies developing therapies that could make a different to people with mental illnesses.

January 25, 2024 - 11 minutesmins - By Willow Shah-Neville

News and Trends 22 Sep 2023

U.S. approval for psychedelic drug MDMA nears after success in clinic

The psychedelic drug MDMA edges closer towards FDA approval for the treatment of post-traumatic stress disorder (PTSD) in the U.S., after promising results of a trial were published. This comes after Australia became the first country to allow doctors to prescribe the drug to those struggling with mental health disorders like PTSD and depression. Recognizing […]

September 22, 2023 - 7 minutesmins - By Roohi Mariam Peter

News and Trends 24 Oct 2022

Beckley Psytech acquires Eleusis Therapeutics

Beckley Psytech Limited has entered into a definitive agreement to acquire clinical-stage life science company Eleusis Therapeutics Limited in an all equity transaction. Under the terms of the agreement, which has been approved by shareholders, Beckley Psytech has acquired 100% of Eleusis, receiving full developmental and commercial rights for the company’s assets, which will further […]

October 24, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 4 Oct 2022

Spinoff Biohaven launches with $258M and “incredible pipeline”

Biohaven Ltd. launched today as a new publicly traded company focused on delivering innovative life-changing treatments for neurological and neuropsychiatric diseases, including rare disorders. As of today, Biohaven has officially begun operating as a separate independent entity as part of the acquisition agreement with Pfizer in May 2022. The company, led by Vlad Coric as […]

October 4, 2022 - 4 minutesmins - By Jim Cornall

News and Trends 25 Jul 2022

Drug for acute treatment of social anxiety disorder did not meet primary endpoint

A nasal spray to treat anxiety did not meet its primary endpoint and was not significantly better than the placebo given during a phase 3 clinical trial. Vistagen Therapeutics Inc’s drug, PH94B, was designed to treat people living with anxiety, depression and other central nervous system (CNS) disorders announced the topline results on Friday (July […]

July 25, 2022 - 4 minutesmins - By Liza Laws

tourette syndrome treatment noema pharma

News and Trends 7 Dec 2020

Swiss Startup Tackles Tourette’s Syndrome Despite Recent Failures

In spite of recent failures of clinical trials from others in the field, Swiss company Noema Pharma is gearing up to develop better treatments for the neurological condition Tourette’s syndrome. Noema Pharma will use a recent €49M Series A round to bankroll the phase I development of a candidate for Tourette’s syndrome along with the […]

December 7, 2020 - 3 minutesmins - By Jonathan Smith

Knowledge hub

Categories

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

Approaches

Therapeutic areas

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Psychiatric disorders

Are next-generation psychedelics the way forward for addressing treatment resistant depression?

Six psychedelic drug companies aiming to revolutionize mental health treatment

Psychedelics sans side effects: neuroplastogens gain ground

Depression drug trials are failing—and placebos are to blame

New treatments being developed for schizophrenia

Psychedelic therapies under scrutiny: What’s next after Lykos’ MDMA rejection?

Eight mental health biotech companies trying to make a difference to people’s lives

U.S. approval for psychedelic drug MDMA nears after success in clinic

Beckley Psytech acquires Eleusis Therapeutics

Spinoff Biohaven launches with $258M and “incredible pipeline”

Drug for acute treatment of social anxiety disorder did not meet primary endpoint

Swiss Startup Tackles Tourette’s Syndrome Despite Recent Failures

Subscribe to our newsletter to get the latest biotech news!

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!